Independent Women’s Forum: Koch-Funded Group Promotes Pesticide, Oil, Tobacco Agendas

Print Email Share Tweet

The Independent Women’s Forum is a 501(c)(3) nonprofit that has taken money from tobacco and oil companies, partners with Monsanto, defends toxic chemicals in food and consumer products, denies climate science and argues against laws that would curb the power of corporations.

IWF began in 1991 as an effort to defend now Supreme Court Justice (and former Monsanto attorney) Clarence Thomas as he faced sexual harassment charges. The group now says it seeks to “improve the lives of Americans by increasing the number of women who value free markets and personal liberty.”

A key message of IWF is to shift the blame for health or environmental problems away from corporations and toward personal responsibility — for example arguing that parents, not food companies, are to blame for America’s obesity problem.

Funding by right wing billionaires and corporations

According to data collected by Greenpeace USA, IWF has received over $15 million in funding since 1998, largely from right-wing foundations that promote deregulation and corporate free reign.

IWF’s leading contributors, with donations topping $5.3 million, are Donors Trust and Donors Capital Funds, the “dark money ATM of the conservative movement” connected with Charles and David Koch. The funds channel money from anonymous donors, including corporations, to efforts that champion corporate agendas, as a Greenpeace investigation established.

IWF’s top funder: dark money from undisclosed donors

IWF has also received $844,115 in combined donations from Koch family foundations. Other top funders include the Sarah Scaife Foundation, the Bradley Foundation, Randolf Foundation (an offshoot of the Richardson Foundation) and Searle Freedom Trust — all are leading funders of climate-science denial, according to a Drexel University study.

ExxonMobil and Philip Morris are among IWF’s funders, according to documents from the UCSF Tobacco Industry Documents Library. Phillip Morris named IWF in a list of “potential third party references” and “those who respect our views.”

The book “Merchants of Doubt” by Naomi Oreskes and Eric Conway described IWF as one of the “seemingly grass-roots organizations” funded by the Phillip Morris Corporation that focus on “Individual Liberties,” “Regulatory Issues,” or both.

Rush Limbaugh has donated at least a quarter of a million dollars to IWF, according to this report in The Nation: “Guess Which Women’s Group Rush Limbaugh has Donated Hundreds of Thousands of Dollars to? Hint: it’s the one that defends him whenever he launches into a sexist tirade.”

IWF leaders

IWF Board Chair Heather R. Higgins has held senior positions in numerous right-wing foundations, including the Randolph Foundation, the Smith Richardson Foundation and the Philanthropy Roundtable.

Kellyanne Conway, White House advisor and former Trump campaign manager, is an IWF board member. Directors Emeritae include Lynne V. Cheney, wife of Dick Cheney and Kimberly O. Dennis, president of the board of directors of Donors Trust and president and CEO of Searle Freedom Trust.

Nancy M. Pfotenhauer, a former Koch Industries lobbyist, left Koch Industries to become president of IWF in 2001 and she later served as Vice Chairman of IWF’s Board of Directors. She has a long history of promoting dirty energy and pushing for deregulation of polluting industries.

IWF’s agenda closely follows the lobbying and messaging agenda of tobacco, oil and chemical industry interests. Following are some examples:

Argues ‘standard Phillips Morris PR’ 

In August 2017, IWF lobbied FDA to approve Phillip Morris’ IQOS e-cigarettes, arguing that women need the products for various biological reasons to help them quit smoking regular cigarettes.

“Clearly, the FDA doesn’t intend to punish women, simply for their gender. Yet, that’s precisely what’s going to happen if women are limited to smoking cessation products that biologically cannot provide them with the help they need to quit traditional cigarettes,” IWF wrote.

In response to the IWF letter, Stanton Glantz, PhD, Professor of Medicine at the UCSF Center for Tobacco Control Research and Education, said: “This is standard Philip Morris PR.  There is no independent confirmation that IQOS are safer than cigarettes or that they help people quit smoking.”

Denies climate science  

The Independent Women’s Forum is a “Koch Industries Climate Denial Group” that “has spread misinformation on climate science and touts the work of climate deniers,” according to Greenpeace.

Jane Mayer reported in The New Yorker: “The (Koch) brothers have given money to more obscure groups, too, such as the Independent Women’s Forum, which opposes the presentation of global warming as a scientific fact in American public schools. Until 2008, the group was run by Nancy Pfotenhauer, a former lobbyist for Koch Industries. Mary Beth Jarvis, a vice-president of a Koch subsidiary, is on the group’s board.”

Opposes teaching climate science in schools

A Denver Post story reported in 2010, IWF “thinks global warming is ‘junk science’ and that teaching it is unnecessarily scaring schoolchildren.” Through a campaign called “Balanced Education for Everyone,” IWF opposed climate science education in schools, which the group described as “alarmist global warming indoctrination.”

IWF President Carrie Lucas writes about the “growing skepticism about climate change” and argues “the public could pay dearly for the hysteria.”

Promotes toxic chemicals / Partners with Monsanto 

IWF is a leading messenger for promoting toxic chemicals as nothing to worry about, opposing public health protections and trying to build trust for corporations like Monsanto. According to IWF’s “Culture of Alarmism” project, sharing information about hazardous chemicals in consumer products leads to “wasted tax dollars, higher costs and inferior goods for consumers, fewer jobs … and a needlessly worried, less free American populace.”

In February 2017, Monsanto partnered with IWF on an event titled “Food and Fear: How to Find Facts in Today’s Culture of Alarmism,” and an IWF podcast that month discussed “How Monsanto is Vilified by Activists.”

IWF pushes the talking points of Monsanto and the agrichemical industry: promoting GMOs and pesticides, attacking the organic industry and opposing transparency in food labels. Examples include:

  • Vermont’s GMO labeling law is stupid. (The Spectator)
  • Sinister GMO labeling will cause grocery costs to skyrocket. (IWF)
  • Anti-GMO hype is the real threat to the well being of families. (National Review)
  • General Mills caved in to the “food police” by removing GMOs (USA Today)
  • Chipotle is stuffing their non-GMO burritos with nonsense. (IWF)
  • Reasonable moms need to push back on the mom shaming and guilt tripping organic food narrative. (IWF podcast)
  • GMO critics are cruel, vain, elite and seek to deny those in need. (New York Post)
  • Educates celebrity moms about GMOs with Monsanto’s talking points (IWF)

Champions corporate-friendly “food freedom”

IWF attacks the U.S. Food and Drug Administration as “government nannies,” for example describing the agency as “food Marxists” and “completely out of control” for issuing voluntary guidance to food manufacturers to cut sodium levels.

A June 2017 IWF event tried to stoke fears about public health guidance

In 2012, IWF launched a “Women for Food Freedom” project to “push back on the nanny state and encourage personal responsibility” for food choices. The agenda included opposing “food regulations, soda and snack food taxes, junk science and food and home-product scares, misinformation about obesity and hunger, and other federal food programs, including school lunches.”

On obesity, IWF tries to shift attention away from corporate accountability and toward personal choices. In this interview with Thom Hartmann, Julie Gunlock of IWF’s Culture of Alarmism Project argues that corporations are not to blame for America’s obesity problem but rather “people are making bad choices and I think parents are completely checking out.” The solution, she said, is for parents to cook more, especially poor parents since they have a worse problem with obesity.

Attacks moms for trying to reduce pesticide exposures 

IWF pushes industry messaging, using covert tactics, in attempt to ostracize moms who are concerned about pesticides; a prime example is this 2014 New York Post article, “Tyranny of the Organic Mommy Mafia” by Naomi Schafer Riley.

Under the guise of complaining about “mom shaming,” Riley – who is an IWF fellow but did not disclose that to readers – attempts to shame and blame moms who choose organic food.

Riley’s article relied on information from industry front groups that she falsely presented as independent sources:

  • Riley described Academics Review – a front group funded by the agrichemical industry and started with the help of Monsanto to attack the organic industry and critics of GMOs – as “a nonprofit group of independent scientists.”
  • Riley used the Alliance for Food and Farming, a food industry front group, to counter “the most common mommy worry — pesticides” with the message that pesticides are nothing to worry about.
  • A key source, Julie Gunlock, was identified as an author but not as an employee of IWF and Riley’s colleague.

Partners with chemical industry front groups

IWF partners with other corporate front groups such as the American Council on Science and Health, a leading defender of toxic chemicals with deep ties to Monsanto and Syngenta. ACSH is funded by chemical, pharmaceutical, tobacco and other industry groups.

  • In a February 2017 IWF podcast, ACSH and IWF “debunked Rachel Carson’s alarmism on toxic chemicals”
  • ACSH was “fully behind” IWF’s “culture of alarmism letter” opposing efforts to remove hazardous chemicals from consumer products.
  • IWF events attacking moms who are concerned about toxic chemicals, such as this “hazmat parenting” event, featured ACSH representative Josh Bloom and chemical industry public relations writer Trevor Butterworth.

As many journalists and articles have pointed out, IWF also partners with many other Koch-funded activist groups that deny climate science and push the deregulatory agenda of corporations.

For further reading: 

The Intercept, “Koch Brothers Operatives Fill Top White House Positions,” by Lee Fang (4/4/2017)

The Nation, “Meet the ‘Feminists’ Doing the Koch Brothers’ Dirty Work,” by Joan Walsh (8/18/2016)

Center for Media and Democracy, “Most Known Donors of the Independent Women’s Forum are Men,” by Lisa Graves (8/24/2016)

Center for Media and Democracy, “Confirmation: the Not-so-Independent Women’s Forum was Born in Defense of Clarence Thomas and the Far Right,” by Lisa Graves and Calvin Sloan (4/21/2016)

Slate, “Confirmation Bias: How ‘Women for Judge Thomas’ turned into a conservative powerhouse,” by Barbara Spindel (4/7/2016)

Truthout, “Independent Women’s Forum Uses Misleading Branding to Push Right Wing Agenda,” by Lisa Graves, Calvin Sloan and Kim Haddow (8/19/2016)

Inside Philanthropy, “The Money Behind the Conservative Women’s Groups Still Fighting the Culture War,” by Philip Rojc  (9/13/2016)

The Nation, “Guess Which Women’s Group Rush Limbaugh has Donated Hundreds of Thousands of Dollars to? Hint: it’s the one that defends him whenever he launches into a sexist tirade,” by Eli Clifton (6/12/2014)

The New Yorker, “The Koch Brothers Covert Operations,” by Jane Mayer (8/30/2010)

Oxford University Press, “Righting Feminism: Conservative Women and American Politics,” by Ronnee Schreiber (2008)

Inside Philanthropy, “Look Who’s Funding This Top Conservative Women’s Group,” by Joan Shipps (11/26/2014)

Fairness and Accuracy in Reporting, “Conservative Women are Right for Media Mainstream; Media Have Finally Found Some Women to Love,” by Laura Flanders (3/1/1996)

Carey Gillam’s presentation to European Parliament hearing on the Monsanto Papers & glyphosate

Print Email Share Tweet

Remarks delivered Oct. 11, 2017 by Carey Gillam before a joint hearing of the European Parliament committees on the Environment, Public Health and Food Safety; and Agriculture and Rural Development.

Links: slides via SlideShare; Carey’s remarks; video of Carey’s presentation and full hearing

Decades of Deceit: How Corporate Influence Has Manipulated Science and Safety Assessments; Revelations from the Monsanto Papers and Other Research

Good morning – I am an investigative journalist, someone who has spent 30 years focusing on facts, pursuing truth. And having spent roughly 20 of those 30 years delving into the dealings of Monsanto I can confidently tell you that the story of the company’s top selling chemical, glyphosate, is not one of truth, but one of deceit – carefully calculated and choreographed deceit. There is overwhelming evidence of attempts to deceive, and to do so in ways that manipulate the press and manipulate policy makers like you.

In my reporting role I – along with colleagues at US Right to Know – have obtained thousands of documents from our US regulators as well as from US scientists who work at public universities, and these documents show clearly the long history of deception when it comes to presentation of glyphosate matters. In addition to those documents, we have now the thousands of pages of internal Monsanto emails, memos and other documents that make it clear beyond any doubt the efforts by this company to manipulate policy makers and members of the public.

You just heard panelists talk about the science. I’m here to share with you what the documents show about deception. We know from the documents that Monsanto has:

  • Ghostwritten research papers that assert glyphosate safety for publication & regulatory review
  • Provided alternative assessments for studies that Indicate harm; convinced regulators to discount evidence of safety problems
  • Developed a network of European & U.S. scientists to push glyphosate safety message to regulators and lawmakers while appearing to be independent of industry
  • Utilized public relations teams to ghostwrite articles and blogs that are posted using names of scientists who appear to be independent
  • Formed front groups that work to discredit journalists and scientists who publicize safety concerns
  • Provided EPA “talking points” to use if questioned by press about IARC classification
  • Successfully pushed EPA to remove top independent epidemiologist from EPA Scientific Advisory Panel
  • Enlisted 3 EPA officials to block a 2015 Glyphosate Review by the U.S. Agency for Toxic Substances and Disease Registry that Monsanto said would likely agree with IARC

For many examples of Monsanto’s manipulations revealed in the documents, see Carey’s slides posted below – slides also available via PDF or SlideShare.  Text of remarks posted here (PDF).



Link to video of Carey Gillam’s presentation and video of full hearing

Carey Gillam is a veteran journalist, researcher, and writer with more than 25 years of experience covering corporate America, and a former senior correspondent for Reuters’ international news service. Her new book “Whitewash: The Story of a Weed Killer, Cancer and the Corruption of Science” was just released by Island Press. Carey is also the research director of U.S. Right to Know, a nonprofit organization that investigates the risks associated with the corporate food system, and the food industry’s practices and influence on public policy.

Whitewash: The Story of a Weed Killer, Cancer and the Corruption of Science

Print Email Share Tweet

Released Oct. 2017: Carey Gillam’s new book about Monsanto, Roundup and glyphosate is available now through Island Press, AmazonBarnes and Noble, or your local independent bookseller.

Hard-hitting, eye-opening narrative…A forceful argument for an agricultural regulatory environment that puts public interest above corporate profits.”  Kirkus Reviews

This is a must-read for everyone concerned about the increasing burden of toxic chemicals in water and food, the health and environmental consequences thereof, and corporate influence on government agencies.Booklist 

“Journalist Gillam exposes a plethora of scientific research, legal materials, and documentary evidence recovered from corporate and government resources to paint a damning picture of the peddling of glyphosate by Monsanto and other agribusinesses … Gillam expertly covers a contentious front where corporate malfeasance intersects with issues of public health and ecology.” Publishers Weekly 

See also: USRTK News Release and Carey Gillam’s testimony before a joint committee of the European Parliament on 10/11/2017

Book Description

It’s the pesticide on our dinner plates, a chemical so pervasive it’s in the air we breathe, our water, our soil, and even found increasingly in our own bodies. Known as Monsanto’s Roundup by consumers, and as glyphosate by scientists, the world’s most popular weed killer is used everywhere from backyard gardens to golf courses to millions of acres of farmland. For decades it’s been touted as safe enough to drink, but a growing body of evidence indicates just the opposite, with research tying the chemical to cancers and a host of other health threats.

In Whitewash, veteran journalist Carey Gillam uncovers one of the most controversial stories in the history of food and agriculture, exposing new evidence of corporate influence. Gillam introduces readers to farm families devastated by cancers which they believe are caused by the chemical, and to scientists whose reputations have been smeared for publishing research that contradicted business interests. Readers learn about the arm-twisting of regulators who signed off on the chemical, echoing company assurances of safety even as they permitted higher residues of the pesticide in food and skipped compliance tests. And, in startling detail, Gillam reveals secret industry communications that pull back the curtain on corporate efforts to manipulate public perception.

Whitewash is more than an exposé about the hazards of one chemical or even the influence of one company. It’s a story of power, politics, and the deadly consequences of putting corporate interests ahead of public safety.

http://careygillam.com/book
Publication date October 2017

Home

More Praise for Whitewash

“The book unravels a tapestry of pesticide industry tricks to manipulate the scientific truths about their products while placing profits above human health and the environment. As someone who has experienced similar actions by corporations firsthand in my work far too often, I am hopeful that Carey’s book will be a wake-up call for more transparency about the dangers surrounding many chemicals in the marketplace.” Erin Brockovich, environmental activist and author

Carey Gillam has brilliantly assembled the facts and describes how Monsanto and other agricultural chemical companies lied about their products, covered up the damaging data and corrupted government officials in order to sell their toxic products around the world.  David Schubert, Ph.D., Professor and Head of the Cellular Neurobiology Laboratory at the Salk Institute For Biological Studies

Carey Gillam is a brave warrior in the mold of Rachel Carson. She has exposed the ruthless greed and fraud which have led to the poisoning of our planet. Brian G.M. Durie, M.D. Chairman of the International Myeloma Foundation, oncology specialist and attending physician at Cedars-Sinai Medical Center

In the grand tradition of Silent Spring, Carey Gillam’s Whitewash is a powerful exposé that sheds light on a chemical that — to most of us — is both entirely invisible and yet profoundly damaging to our bodies and our environment. It is a deeply researched, entirely convincing exposé of the politics, economics and global health consequences implicit in the spread of the world’s most common herbicide. Gillam has done what all great journalists strive to do: she has made us see clearly what has long been right before our eyes. Highly recommended.  McKay Jenkins, author, Professor of English, Journalism and Environmental Humanities at the University of Delaware

Q&A with Carey Gillam on Whitewash

Print Email Share Tweet

Carey Gillam’s new book is available now from Island Press: Whitewash: The Story of a Weed Killer, Cancer, and the Corruption of Science

Gilliam’s Whitewash is a hard-hitting investigation into the most widely used agrichemical in history, based on 20 years of research and scores of internal industry documents. For decades glyphosate has been lauded as the chemical that’s “safe enough to drink,” but a growing body of scientific research ties glyphosate to cancers and a host of other health and environmental threats.

Whitewash is a “must-read,” says Booklist.  Kirkus Reviews calls Whitewash a “hard-hitting, eye-opening narrative,” and a “forceful argument for an agricultural regulatory environment that puts public interest above corporate profits.”

Q: Carey, you’ve been reporting on pesticides and Monsanto for nearly 20 years. As a journalist, why was it important to write a book about the topic? Why now?

A: Health experts around the world recognize that pesticides are a big contributor to a range of health problems suffered by people of all ages, but a handful of very powerful and influential corporations have convinced policy makers that the risks to human and environmental health are well worth the rewards that these chemicals bring in terms of fighting weeds, bugs, or plant diseases. These corporations are consolidating and becoming ever more powerful, and are using their influence to push higher and higher levels of many dangerous pesticides into our lives, including into our food system. We have lost a much-needed sense of caution surrounding these chemicals, and Monsanto’s efforts to promote increased uses of glyphosate is one of the best examples of how this corporate pursuit of profits has taken priority over protection of the public.

Q: People may not be familiar with the term “glyphosate” or even “Roundup.” What is it? Why should people care?

A: Roundup herbicide is Monsanto’s claim to fame. Well before it brought genetically engineered crops to market, Monsanto was making and selling Roundup weed killer. Glyphosate is the active ingredient—the stuff that actually kills the weeds—in Roundup. Glyphosate is also now used in hundreds of other products that are routinely applied to farm fields, lawns and gardens, golf courses, parks, and playgrounds. The trouble is that it’s not nearly as safe as Monsanto has maintained, and decades of scientific research link it to a range of diseases, including non-Hodgkin lymphoma.

Monsanto has known about these risks and worked very hard to hide them.

Monsanto has known about these risks and worked very hard to hide them while promoting more and more use. Monsanto’s genetically engineered crops are all built to encourage glyphosate use. The key genetic trait Monsanto has inserted into its GMO soybeans, corn, canola, sugar beets, and other crops is a trait that allows those crops to survive being sprayed directly with glyphosate. After Monsanto introduced these “glyphosate-tolerant” crops in the mid-1990s, glyphosate use skyrocketed. Like other pesticides used in food production, glyphosate residues are commonly found in food, including cereals, snacks, honey, bread, and other products.

Q: You write that Whitewash shows we’ve forgotten the lessons of Rachel Carson and Silent Spring. What do you mean by that?

A: Carson laid out the harms associated with indiscriminate use of synthetic pesticides, and she predicted the devastation they could and would bring to our ecosystems. She also accused the chemical industry of intentionally spreading disinformation about their products. Her book was a wake-up call that spurred an environmental movement and led to the creation of the Environmental Protection Agency. But over the decades since, the general population and certainly our politicians and regulators have clearly forgotten the need for caution and scrutiny in dealing with these pesticides and the companies that profit from them. You see a push by our political leaders for fewer regulations, for more unchecked use of glyphosate and other pesticides in our food production, while research about how these pesticides cause cancer, how they harm children’s brain development, and how they alter reproductive health all get pushed aside.

Q: You obtained industry communications and regulatory documents that reveal evidence of corporate influence in regulatory agencies like the EPA. Does the evidence you uncovered take on new significance in light of the current political climate in the US? How can people keep regulatory agencies accountable for working in the public’s best interest?

A: Yes, it’s quite clear that Monsanto and other corporate giants like Dow Chemical enjoy significant sway with regulators, the very people who are supposed to be protecting the public. The companies use their money and political power to influence regulatory decision- making as well as the scientific assessments within the regulatory agencies. If we consumers and taxpayers want to protect our children, our families, our future, we need to pay attention, educate ourselves on these issues, write and call our lawmakers, and support organizations working on our behalf to protect our health and environment. We need to be proactive on policies that protect the public, not the profits of giant corporations. Capitalism is great—the pursuit of wealth through a free marketplace provides much that is good, that is true. But when we let corporate profit agendas take precedence over the health and well- being of our people and our planet we’re sacrificing far too much.

Q: Monsanto attempted to censor and discredit you when you published stories that contradicted their business interests. What strategies can journalists—or scientists— employ when faced with this pushback? What are the stakes if they don’t?

A: Monsanto, and organizations backed by Monsanto, have certainly worked to undermine my work for many years. But I’m not alone; they’ve gone after reporters from an array of major news outlets, including the New York Times, as well as scientists, academics, and others who delve too deeply into the secrets they want to keep hidden. I see it as a badge of honor that Monsanto and others in the chemical industry feel threatened enough by our work to attack us. It’s certainly not easy, for journalists in particular, to challenge the corporate propaganda machine.

Reporters that go along with the game, repeat the talking points, and publish stories that support corporate interests are rewarded with coveted access to top executives and handed “exclusive” stories about new products or new strategies, all of which score them bonus points with editors. In contrast, reporters who go against the grain, who report on unflattering research, or who point out failures or risks of certain products often find they lose access to key corporate executives. The competition gets credit for interviews with top corporate chieftains while reporters who don’t play the game see their journalistic skills attacked and insulted and become the subject of persistent complaints by the corporate interests to their editors.

What can be done? Editors and reporters alike need to check their backbones, realize that the job of a journalist is to find the story behind the spin, to ask uncomfortable questions and to forge an allegiance only to truth and transparency. When we lose truthful independent journalism, when we’re only hearing what the powerful want heard, it’s assured that those without power will be the ones paying the price.

Q: You interviewed a huge number of people for this book, including scientists, farmers, and regulators. Is there a particular conversation or story that stands out to you?

A: I’ve interviewed thousands of people over my career, from very big-name political types to celebrities to every day men and women, and I find it’s always those who are most unassuming, those “regular folk” who grab my heart. In researching this book, the individual story that most resonated with me is that of Teri McCall, whose husband Jack suffered horribly before dying of cancer the day after Christmas in 2015. The McCall family lived a quiet and rather simple life, raising avocadoes and assorted citrus fruits on their Cambria, California farm, using no pesticides other than Roundup in their orchards. Jacks’ death from non-Hodgkin lymphoma, a type of cancer linked to glyphosate, fully devastated Teri and her children and grandchildren. She has shown so much grace and strength and she gave me so much of her time—and her tears—in telling me Jack’s story. She is a woman I truly admire.

Of course there are so many others I have learned from, who I feel for, including the     scientists who have struggled to publish research, who have been censored or worse for their findings of harm associated with glyphosate and other pesticides. And farmers—I have   so much regard for farmers generally, including each and every one interviewed for this book. The work they do to raise our food is incredibly challenging and they are on the front lines of the pesticide dangers every day.

Jaw-dropping is the best way to describe some of the documents I and others have uncovered.

Q: You’ve been immersed in this topic for years. Was there anything you found in the course of researching and writing this book that surprised you?

A: Jaw-dropping is the best way to describe some of the documents I and others have uncovered. Seeing behind the curtain, reading in their own words how corporate agents worked intentionally to manipulate science, to mislead consumers and politicians, was shocking. As a long-time journalist, I’m a bit of a hardened cynic. Still, the depth of the deception laid bare in these documents, and other documents still coming to light, is incredible.

Q: What do you hope readers take away from Whitewash?

A: A writer at the New York Times told me after reading Whitewash that she feared eating anything in her refrigerator because of the information the book provides about the range of pesticide residues found in so many food products. That definitely is not my goal, to frustrate or frighten people. But I do hope that readers will be moved to care more about how our food is produced, how we make use of dangerous synthetic pesticides not just on farms but also on schoolyards and in parks where our children play.

And I hope they will want to be engaged in the larger discussion and debate about how we build a future that adequately balances the risks and rewards associated with these pesticides. As Whitewash shows, the current system is designed to pump up corporate profits much more than it is to promote long-term environmental and food production sustainability. There are many powerful forces at work to keep the status quo, to continue to push dangerous pesticides, almost literally down our throats. It’s up to the rest of us to push back.

Carey Gillam is a veteran journalist, researcher, and writer with more than 25 years of experience covering corporate America. A former senior correspondent for Reuters’ international news service, Gillam digs deep into the big business of food and agriculture. Carey is also the research director of U.S. Right to Know, a nonprofit organization that investigates the risks associated with the corporate food system, and the food industry’s practices and influence on public policy.

Carey Gillam Launches Book on Pesticide Problems & Monsanto Influence; Called to Appear Before EU Parliament

Print Email Share Tweet

News Release
For Immediate Release: Tuesday, October 10, 2017
For More Information Contact: Stacy Malkan (510) 542-9224                       

Today, Carey Gillam, a former Reuters reporter and current research director for U.S. Right to Know, launched her new book, Whitewash: The Story of a Weed Killer, Cancer and the Corruption of Science (Island Press), a hard-hitting investigation into the pesticide at the center of a regulatory and legal maelstrom on both sides of the Atlantic.

Tomorrow, Gillam will appear as an invited expert before members of the European Parliament at a joint committee hearing to discuss Monsanto’s efforts to manipulate science and regulatory assessments on glyphosate.

Gillam’s book and testimony are based on 20 years of research and scores of industry documents that describe the patterns of deception surrounding Monsanto’s flagship weed killer Roundup and its active ingredient glyphosate, and the impacts on people and the environment.

According to Publishers Weekly, “Gillam expertly covers a contentious front where corporate malfeasance intersects with issues of public health and ecology.” Kirkus Reviews calls Whitewash “a hard-hitting, eye-opening narrative,” and a “forceful argument for an agricultural regulatory environment that puts public interest above corporate profits.”

As Whitewash details, glyphosate is the most widely used agrichemical in history—a pesticide so pervasive it’s in our air, our water, our food, and even our own bodies. For decades it’s been lauded as the chemical that’s “safe enough to drink,” but a growing body of scientific research ties glyphosate to cancers and a host of other health and environmental threats.

Whitewash explores the legal claims of thousands of Americans who allege Roundup caused their cancers, and exposes the powerful influence of a multi-billion-dollar industry that has worked for decades to keep consumers in the dark and regulators in check. The book reveals how political influence has been at work for years in regulatory agencies while also laying bare unappetizing truths about the levels of glyphosate and other pesticides commonly found in our food products.

Whitewash makes clear that 55 years after Rachel Carson and Silent Spring awakened the world to the dangers of unchecked pesticide use, we have failed to heed her warnings.

Recent news about Monsanto’s actions on glyphosate:

New York Times:Monsanto’s Roundup Faces European Politics and US Lawsuits,” by Danny Hakim, Oct. 4, 2017

Le Monde Series:

The Guardian:Monsanto Banned from EU Parliament,” by Arthur Neslen, Sept. 28, 2017

USRTK: How Monsanto Manufactured ‘Outrage’ Over IARC Cancer Classification of Glyphosate,” by Carey Gillam, Sept. 19, 2017

Carey Gillam is a veteran journalist, researcher, and writer with more than 25 years of experience covering corporate America. A former senior correspondent for Reuters’ international news service, Gillam digs deep into the big business of food and agriculture.

U.S. Right to Know is a nonprofit organization that investigates the risks associated with the corporate food system, and the food industry’s practices and influence on public policy.

-30-

The Misleading and Deceitful Ways of Dr. Kevin Folta

Print Email Share Tweet

Kevin Folta, Ph.D., professor and chairman of the Horticulture Sciences Department at University of Florida, has provided inaccurate information and engaged in misleading activities in his efforts to promote genetically engineered foods and pesticides.

His recent lawsuit against The New York Times is the latest in a long line of examples of Dr. Folta’s misleading and deceptive communications.

Dr. Folta sues NY Times and two-time Pulitzer Prize winner for reporting his ties to Monsanto

On Sept. 1, 2017, Dr. Folta filed a lawsuit against The New York Times and Eric Lipton, a two-time Pulitzer Prize winning journalist, claiming they defamed him with a 2015 front-page article that described how Monsanto enlisted academics to oppose the labeling of genetically engineered foods.

Lawsuit documents:
Amended complaint (10/5/2017)
NYT motion to dismiss (10/19/2017)

Dr. Folta’s lawsuit claims the defendants “misrepresented him as a covertly paid operative of one of the largest and most controversial companies in America, Monsanto,” and that they did so in order to “to further their own ‘anti GMO’ agenda.”

According to Dr. Folta’s lawsuit, Lipton “has almost singlehandedly silenced the scientific community from teaching scientists how to communicate.”

The lawsuit claims that Dr. Folta “never received” an “unrestricted grant” from Monsanto and that he “never received any form of grant, and never received support for him to ‘travel around the country and defend genetically modified foods.’”

However, documents show that Monsanto provided Dr. Folta with, in their words, “an unrestricted grant in the amount of $25,000 which may be used at your discretion in support of your research and outreach projects.”

Emails indicate that Monsanto donated the money in response to a 9-page proposal from Dr. Folta, in which he asked Monsanto for $25,000 to fund his “three tiered solution” to the “biotech communications problem.” Proposed activities included traveling each month to a major domestic university to promote GMOs. The money was donated to a food bank after the documents became public.

Dr. Folta’s lawsuit also claims (point 67), “Dr. Folta does not discuss industry products of any sort, he teaches broadly about technology.” Yet he has vouched for the supposed safety of Monsanto’s RoundUp, going so far as to drink the product “to demonstrate harmlessness.” He has also said he “will do it again.”

Dr. Folta has repeatedly claimed no association with Monsanto despite his close collaboration with Monsanto  

Dr. Folta stated numerous times that he had no connection to Monsanto. Yet emails reported by The New York Times established that he was in frequent contact with Monsanto and their public relations allies to collaborate on activities to promote genetically engineered foods.

The emails indicate that Monsanto and allies set up media opportunities and lobbying activities for Dr. Folta and worked with him on messaging. In August 2014, Monsanto informed Dr. Folta that he would receive $25,000 to further his promotional activities. The email exchanges suggest a close collaboration:

  • In July 2014, a Monsanto executive praised Dr. Folta’s grant proposal and asked four other Monsanto executives to provide feedback to improve it. He wrote, “This is a great 3rd-party approach to developing the advocacy that we’re looking to develop.”
  • In August 2014, Dr. Folta responded to the acceptance letter for his grant, “I’m grateful for this opportunity and promise a solid return on the investment.”
  • In October 2014, Dr. Folta wrote to a Monsanto executive, “I’m glad to sign on to whatever you like, or write whatever you like.”

Just weeks after the grant details were worked out, Dr. Folta asserted that he had “no formal connection to Monsanto.” He later said he received “no research or personal funding” from “Big Ag,” had “no financial ties to any of the Big Ag companies that make transgenic crops, including Monsanto,” and had “nothing to do with MON.”

Dr. Folta proposed hiding the Monsanto money from public scrutiny

“My funding is all transparent,” Dr. Folta wrote in his blog, but his proposal to Monsanto to fund his GMO promotional activities concluded with a paragraph advising Monsanto how to donate the money to avoid public disclosure:

“If funded directly to the program as a SHARE contribution (essentially unrestricted funds) it is not subject to IDC and is not in a ‘conflict-of-interest’ account. In other words, SHARE contributions are not publicly noted. This eliminates the potential concern of the funding organization influencing the message.”

Monsanto sent the $25,000 donation as an unrestricted grant for Dr. Folta.

Dr. Folta allowed an industry PR firm to ghostwrite for him, then denied it

An August 2015 story in Inside Higher Ed described allegations that the agrichemical industry’s PR firm, Ketchum, had provided Dr. Folta with “canned answers to questions about GMOs” for the agrichemical industry’s public relations website, GMO Answers.

Dr. Folta denied using the ghostwritten text, according to the story:

“Regarding the canned answers, he said he was ‘pissed off’ when he received them and never used them.”

Dr. Folta later admitted using the ghostwritten text. The New York Times reported in September 2015:

“But Ketchum did more than provide questions (for GMO Answers). On several occasions, it also gave Dr. Folta draft answers, which he then used nearly verbatim, a step that he now says was a mistake.”

In an October 2015 BuzzFeed story, Dr. Folta justified his decision to use Ketchum’s ghostwritten text:

“They gave me extremely good answers that were spot on,” Folta told me. “I’m inundated with work. Maybe it was lazy, but I don’t know that it was lazy. When someone says, ‘We’ve thought about this and here’s what we have’ — there are people who work in academia who have speechwriters who take the words of other people and present them as their own. That’s OK.”

Dr. Folta posted false information about agrichemical industry funding to the University of Florida

In October 2014, Dr. Folta posted inaccurate information about his own university’s funding on GMO Answers. When asked, “How much have the biotech companies donated to the Horticultural Sciences Department, University of Florida?” Dr. Folta responded:

“There are zero ‘donations.’ At least during the last five years (all I checked), there are not even any grants or research agreements between the Horticultural Sciences Department at U.F. and any company selling biotech seeds …

During the last five years, at the whole university, there were a total of $21,000 in Monsanto grants to one faculty member in the panhandle who studies weeds. That’s it for the whole university. Our records are all public, so anyone could have found this information.”

In fact, biotech companies donated more than $12 million to the University of Florida in fiscal year 2013/2014 alone, according to University of Florida Foundation documents posted by NYT. Monsanto was listed as a “Gold” donor that year, meaning the company had donated at least $1 million. Syngenta was a “Diamond” donor with “Cumulative Giving of $10 Million+” while BASF donated at least $1 million and Pioneer Hi-Bred gave at least $100,000.

University of Florida has a ‘stance’ on GMOs that is ‘harmonious’ with Monsanto, and Dr. Folta is in charge of promoting it  

Leaders at the University of Florida believe it is the university’s role to educate the masses about GMOs and they share a “stance” with Monsanto, according to an email obtained by the US Right to Know investigation.

David Clark, professor of horticultural biotechnology & genetics and director of the University of Florida Institute of Food and Agricultural Sciences Plant Innovation Program (UF/IFAS), wrote to Monsanto executive Robb Fraley on July 21, 2014:

“I thought your talk was excellent and very timely for our community, and it is harmonious with the stance we are taking on GMOs at the University of Florida. Also, thank you for taking a few minutes to chat with me afterward about how we should be educating the 80% of the consumer population who know very little about the technology.

After returning to Gainesville, I communicated with Drs. Kevin Folta and Jack Payne about our discussion. Kevin is our lead spokesperson at UF on the GMO topic and he has taken on the charge of doing just what we discussed – educating the masses. Jack is our Senior VP for IFAS, and just last week he released a video showing just where UF/IFAS stands on the GMO issue: http://www.floridatrend.com/article/17361/jack-payne-of-uf-on-gmos-and-climate-change Both of them are extremely passionate about this issue, and together they are ramping up their efforts to spread the good word.”

In the video, Dr. Payne claims, “there is no science that agrees with these folks that are afraid of GMOs.” In fact, many scientists and studies have raised concerns about GMOs.

Dr. Folta partnered with two groups that mislead journalists and scientists about their industry funding

A June 2014 conference to promote GMOs called the “Biotech Literacy Project Boot Camp” was billed as a partnership between University of Florida, Genetic Literacy Project and Academics Review.

The co-sponsors of the 2014 Florida boot camp and a 2015 boot camp at UC Davis – Genetic Literacy Project and Academics Review – told scientists and journalists that the events were funded by a combination of government, academia and industry.

In 2015, journalist Brooke Borel reported in Popular Science:

“The conference in question was called the Biotech Literacy Project Boot Camp. I was invited to attend and to speak on some panels, although it wasn’t initially clear what that would involve. I was offered a $2,000 honorarium, as well as expenses. I wrote back and asked who would provide the honorarium and was told it’d be a combination of funds from UC Davis, USDA, state money, and the Biotechnology Industry Organization (BIO).”

In a 2016 email to scientists, Bruce Chassy of Academics Review claimed industry was “indirectly a sponsor” of the Biotech Literacy Project Boot Camps:

“The 3-day bootcamp is relatively expensive since we pay everyone’s travel and lodging as well as honoraria. Participants received $250 and presenters as much as $2,500 (journalists aren’t inexpensive) … I need to be clear up front that our support comes from BIO, USDA, state-USAID and some foundation money, so industry is indirectly a sponsor. We are 100% transparent about sponsorship.”

However, those government and academic sources denied giving any funds to the Biotech Literacy Project Boot Camps, according to reporting by Paul Thacker in The Progressive. Thacker wrote, “the only traceable money source is the biotech industry.”

Thacker reported:

“When contacted, BIO confirmed that it gave Academics Review $175,000 for the 2014 conference at the University of Florida and $165,000 for the 2015 conference at UC-Davis. But BIO added that the money was cycled through a nonprofit it operates called the Council on Biotechnology Information (CBI). In fact, the tax forms for CBI state that it gave a total of $300,000 to Academics Review in both 2014 and 2015. And tax forms for Academics Review, which Chassy runs with his wife, note that the group spent more than $160,000 on the UC-Davis conference in 2015.”

Both Academics Review and Genetic Literacy Project have a history of misleading the public about their funding and activities to defend the agrichemical industry.

  • Academics Review has claimed many times to be an independent group, yet emails obtained by US Right to Know revealed that Academics Review was set up as a front group with the help of Monsanto, while “keeping Monsanto in the background so as not to harm the credibility of the information.”
  • The “financial transparency” note on the Genetic Literacy Project website is inaccurate, changes often and has at times contradicted itself. GLP director Jon Entine also has many close ties to Monsanto

Dr. Folta described the food movement as a “terrorist faction”

Dr. Folta wrote the forward for a 2015 book called “Fear Babe: Shattering Vani Hari’s Glass House.” The forward describes the food movement as a terrorist faction, which Folta names “Al Quesadilla”:

“Al Quesadilla is a moniker ascribed to a modern day elite and well financed terrorist faction sworn to use fear to force political change around food. Al Quesadilla has a central mission – to impose their beliefs about food and food production on the broader society. Their beliefs are religious in nature. They are deeply heartfelt and internalized. Their beliefs are grounded in a misinterpretation of nature, a mistrust of corporate culture and a skepticism of modern science …

Al Quesadilla is an agile and sneaky terrorist group. Like all terrorists, they achieve their objectives through the implementation of fear and coercion. They plan careful strikes on vulnerable targets – American consumers…”

The book, published by Senepath Press, was authored by Mark Alsip, a blogger for Bad Science Debunked, Marc Draco, a “veteran member” of the Banned by Food Babe Facebook page, and Kavin Senapathy, a Forbes contributor who had some of her articles deleted by Forbes.

The book promotes GMOs, claims MSG and aspartame are “harmless” and purports to describe “the facts behind those pesticide scares.”

Dr. Folta promotes pesticide propaganda

Dr. Folta dismisses concerns about pesticide exposure with propaganda claims, not science. For example, he made and failed to correct his guest on many dubious statements about the safety of pesticides in this 2015 podcast interview with Yvette d’Entremont, the “SciBabe.” Folta claimed:

  • If someone is concerned about pesticide exposures, “ask them if they have symptoms of pesticide poisoning. Unless they have symptoms of pesticide poisoning, there’s probably nothing to worry about.”
  • “Your risk from any kind of, especially, pesticide exposure from consumption is probably somewhere between 10,000 and a million times lower than a car accident.”

Dr. Folta’s deceptive communication tactics

Another example of misleading communication associated with Dr. Folta is documented in a 2015 BuzzFeed story by Brooke Borel. The story recounts Borel’s discovery that Dr. Folta used a false identity to interview scientists and even himself on a podcast called the “The Vern Blazek Science Power Hour.”

For further reading:

New York Times, “Food Industry Enlisted Academics in GMO Lobbying War, Emails Show,” by Eric Lipton (9/6/2015)

Emails posted by The New York Times

The Progressive, “Flacking for GMOs: How the Biotech Industry Cultivates Positive Media,” by Paul Thacker (7/21/2017)

Huffington Post, “Keith Kloor’s Enduring Love Affair with GMOs,” by Paul Thacker (7/19/2017)

Global News, “Documents Reveal Canadian Teenager Target of GMO Lobby,” by Allison Vuchnich (12/22/2015)

Nature Biotechnology, “Standing up for Transparency,” by Stacy Malkan (1/2016)

Mother Jones, “These Emails Show Monsanto Leaning on Professors to Fight the GMO War,” by Tom Philpott (10/2/2015)

BuzzFeed, “Seed Money: Confessions of a GMO Defender,” by Brooke Borel (10/19/2015)

USRTK Short Report, “Journalists Failed to Disclose Sources’ Funding from Monsanto”

Independent Science News, “The Puppetmasters of Academia (or What the NYT Left Out),” by Jonathan Latham (9/8/2015)

USRTK letter to Dr. Folta about our FOIA requests

How Monsanto Manufactured ‘Outrage’ at IARC over Cancer Classification

Print Email Share Tweet
By Carey Gillam

Three years ago this month Monsanto executives realized they had a big problem on their hands.

It was September 2014 and the company’s top-selling chemical, the weed killer called glyphosate that is the foundation for Monsanto’s branded Roundup products, had been selected as one among a handful of pesticides to undergo scrutiny by the World Health Organization’s International Agency for Research on Cancer (IARC). Monsanto had spent decades fending off concerns about the safety of glyphosate and decrying scientific research indicating the chemical might cause cancer or other diseases. And even though the IARC review was still months away, Monsanto’s own scientists knew what the outcome would likely be—and they knew it wouldn’t be good.

Internal company records show not just the level of fear Monsanto had over the impending review, but notably that company officials fully expected IARC scientists would find at least some cancer connections to glyphosate. Company scientists discussed the “vulnerability” that surrounded their efforts to defend glyphosate amid multiple unfavorable research findings in studies of people and animals exposed to the weed killer. In addition to epidemiology studies, “we also have potential vulnerabilities in the other areas that IARC will consider, namely, exposure, genetox and mode of action…” a Monsanto scientist wrote in October 2014. That same email discussed a need to find allies and arrange funding for a “fight”—all months before the IARC meeting in March 2015.

And Monsanto predicted internally before IARC even met that the review of the scientific evidence would result in a decision that glyphosate “possibly” was carcinogenic or “probably” was. Monsanto officials had forecast the IARC decision in an internal “preparedness” plan that warned colleagues to “assume and prepare for the outcome…” The document shows Monsanto thought it most likely that IARC would peg glyphosate as a “possible human carcinogen.” The rating of probable carcinogen was “possible but less likely,” the Monsanto memo stated. IARC ultimately did classify glyphosate as “probably carcinogenic to humans.”

As the IARC meeting loomed, the internal documents show that Monsanto did not wait for the actual IARC decision before acting. It enlisted teams of PR and lobbying experts, scientists and others in a plan aimed at creating what was designed to appear as a storm of “outcry” and “outrage” to follow the IARC classification. IARC had a history of “questionable and politically charged rulings,” the Monsanto memo said.

The plan was to create enough controversy to thoroughly discredit IARC’s evaluation because Monsanto officials knew that regulators would be influenced by IARC, and continued widespread use of the top-selling chemical could be at risk.

“It is possible that IARC’s decision will impact future regulatory decision making,” Monsanto stated in its internal correspondence.

The timing was critical because in 2015 both the U.S. Environmental Protection Agency (EPA) and the European Commission were evaluating re-authorizations of Monsanto’s weed killer. Following IARC’s classification, both the European Union and the EPA delayed final decisions on glyphosate amid the still-brewing debate over the chemical’s safety.

“What this indicates to me is that it was obvious to Monsanto that there was evidence of carcinogenicity,” said Peter Infante, an epidemiologist who worked for more than 24 years for the U.S. government studying cancer risks to workers from exposure to toxic substances. “It would seem to me that Monsanto does not like the public to be informed of the cancer hazard.”

“What this indicates to me is that it was obvious to Monsanto that there was evidence of carcinogenicity.”

After the IARC ruling, a storm of protest did erupt from various individuals and organizations alongside Monsanto’s howls of indignant outrage. Some have questioned the wisdom of U.S. funding for IARC and Monsanto has perpetuated a false narrative that the chairman of the IARC working group withheld critical information from the team.

The document trail, which includes internal emails, memos and other communications obtained from Monsanto by plaintiffs’ attorneys through litigation pending in the U.S., makes clear that the debate over, and challenge to, IARC’s classification did not sprout authentically from a variety of voices, but rather was manufactured by Monsanto in advance of IARC’s decision and continued afterward. The goals was—and is—to convince regulators to discount the findings of the team of independent scientific experts who made up the IARC team that examined glyphosate.

The internal records obtained through litigation, combined with documents obtained through Freedom of Information Act (FOIA) and state records requests also show that the actions employed to discredit IARC were part of a decades-long pattern of deceptive tactics by Monsanto to persuade regulators, lawmakers and members of the press and public that glyphosate and Roundup are safe. The company has used these tactics multiple times over the years to try to discredit several scientists whose research has found harmful effects associated with glyphosate.

Orchestrate Outcry”

The IARC attack plan, which was laid out in a February 2015 memo, involved not only Monsanto’s internal PR people, scientists and marketing experts, but a range of outside industry players. Various individuals were assigned tasks. The “strategies and tactics” included:

  • “Orchestrate Outcry” with IARC Decision—Industry conducts robust media/social media outreach on process and outcome.
  • “Identify/request third-party experts to blog, op/ed, tweet and/or link, repost, retweet, etc.” The documents show one such “expert,” academic Henry Miller, was provided a draft article to submit to Forbes for publication under his name with no mention of Monsanto’s involvement. Forbes learned of the deceit last month and severed relations with Miller.
  • “Inform/Inoculate/Engage Industry Partners”—Notably the industry partners listed included three organizations that purport to be independent of Monsanto but have long been seen by critics as front groups for the company—Monsanto named Academics Review and the Genetic Literacy Project, both based in the U.S. and Sense About Science. which has run operations in the United Kingdom and the U.S., as groups to help with its mission. In fact, Sense About Science was the group identified by Monsanto to lead the industry response and “provide a platform for IARC observers.” The groups did as Monsanto planned, posting scathing attacks on IARC on their websites.
  • Engagement with Regulatory Agencies—Monsanto planned for grower associations/ growers to “write regulators with an appeal that they remain focused on the science, not the politically charged decision by IARC.”
  • “Push opinion leader letter to key daily newspaper on day of IARC ruling” with assistance of the Potomac Group marketing firm.

The preparedness plan also called for supporting “the development of three new papers on glyphosate focused on epidemiology and toxicology.” As planned, shortly after the IARC decision Monsanto arranged for several scientists—many of them former employees or paid consultants—to author and publish research papers supporting glyphosate safety. It was revealed through discovery documents that Monsanto discussed ghostwriting the papers. In one email, company scientist William Heydens told colleagues the company could “ghost-write” certain reports that would carry the names of outside scientists—”they would just edit & sign their names so to speak,” he wrote. He cited as an example a 2000 study that has been regarded as influential by regulators. Documents show Monsanto’s heavy writing and editing involvement in the resulting purportedly “independent” review.

Monsanto has adamantly denied ghostwriting, but one memo from August 2015 from the files of Monsanto scientist David Saltmiras actually uses that term, stating that he “ghostwrote cancer review paper Greim et al (2015)…” referring to a paper that showed authorship by German scientist Helmut Greim along with Saltmiras. (Monsanto has acknowledged that Greim worked as a consultant to the company with part of his job being to publish peer-reviewed data on glyphosate).

Another internal email illustrates the writing by a Monsanto scientist of a research paper titled “Developmental and Reproductive Outcomes… after Glyphosate Exposure.” The scientist, Donna Farmer, did extensive work, including what she called a “cut and paste” of certain information. But her name was not included as an author before the paper was submitted to a journal. The published version concluded there was “no solid evidence linking glyphosate exposure to adverse developmental or reproductive effects.”

The paper trail of documents also show that Monsanto feared that a U.S. health agency planning to review glyphosate in 2015 might agree with IARC and collaborated with the EPA to successfully block that agency—the Agency for Toxic Substances & Disease Registry (ATSDR)—from doing its review. “We’re trying to do everything we can to keep from having a domestic IARC occur,” a company official wrote. 

The record also shows that well before IARC, Monsanto recruited networks of academic scientists in the U.S and Europe who have defended Monsanto’s products, including its weed killer, without declaring their collaborations with Monsanto. And that these silent soldiers helped Monsanto discredit scientists who reported research showing harm associated with glyphosate and Roundup, including working at Monsanto’s bidding to get one damaging study by French scientist Gilles-Éric Séralini retracted from a scientific journal where it was published in September 2012. The company even discounted concerns by one of its own paid consultants who found evidence of glyphosate’s genotoxicity and refused to do the additional tests he recommended.

If what Monsanto says is true, that glyphosate is so very safe, and that there is no evidence it causes cancer or other health problems, then why all the smoke and mirrors? Why would the company need to ghostwrite research papers to present to regulators? Why would Monsanto need to establish networks of scientists to promote glyphosate safety and to tear down scientists whose research raises concerns? Why would Monsanto try to block a review of glyphosate by the U.S. ATSDR?

Two committees of the European Parliament have scheduled a hearing for Oct. 11 in Brussels to delve into these and other questions as the European Commission faces a looming deadline for making a decision on the re-authorization of glyphosate before the end of 2017.

Lawmakers should take note of evidence that their own food safety agency appears to have dropped the ball on independent assessments of glyphosate research. Records show that the European Food Safety Authority (EFSA) dismissed a study linking Monsanto’s weed killer to cancer at the advice of an EPA official who Monsanto deemed “useful” and who is part of a probe now into possible collusion between the EPA and Monsanto.

They should also pay heed to news that EFSA based its recommendation on glyphosate on a report that copied and pasted analyses from a Monsanto study.

Monsanto Chairman Hugh Grant was invited to address the Parliament meeting in October, but declined to appear or to send anyone else from Monsanto. Dr. Roland Solecki, head of chemical safety for the German Federal Institute for Risk Assessment (BfR), has also declined, according to organizers. I do plan to participate, as will a representative from IARC and several others.

Throughout this debate, it is worthwhile to remember that the concerns about glyphosate safety have deep roots that date all the way back to at least 1985 when EPA toxicologists looked at data showing rare tumors in mice dosed with glyphosate and determined that glyphosate was “possibly carcinogenic to humans.”

Monsanto protests eventually reversed that classification but in light of all of the deceptive tactics recently revealed in documents, the words of an EPA scientist more than 30 years ago are worth considering today: “Glyphosate is suspect… Monsanto’s argument is unacceptable.”

The EPA scientist in that 1985 memo also wrote: “Our viewpoint is one of protecting the public health when we see suspicious data. It is not our job to protect registrants…”

European lawmakers would be wise to recall those words.

This article was originally published in EcoWatch.

Carey Gillam is a veteran reporter and author of Whitewash – The Story of a Weed Killer, Cancer and the Corruption of Science. She is research director for U.S. Right to Know, a nonprofit consumer watchdog group working for truth and transparency in our food system.  

Why You Can’t Trust Henry Miller

Print Email Share Tweet

Henry I. Miller writes in defense of polluting industries.

Henry I. Miller, MD, has a long history of arguing for deregulation of hazardous products and taking positions outside the scientific mainstream. He has claimed nicotine “is not particularly bad for you,” argued that low levels of radiation may be beneficial to health, and has repeatedly called for the re-introduction of the insecticide DDT. He is perhaps the most prolific and best-known promoter of genetically engineered foods, writing for the Wall Street Journal, New York Times, Los Angeles Times, Forbes and other outlets.

In August 2017, Forbes deleted all columns authored or co-authored by Miller in the wake of revelations that Monsanto ghostwrote a column that Miller published under his own name in Forbes.

Miller is a fellow at the Hoover Institution and was the founding director of the FDA’s Office of Biotechnology. He does not disclose his funding.

Monsanto Ghostwriting / Dropped by Forbes

On August 1, 2017, the New York Times reported:

“Documents show that Henry I. Miller asked Monsanto to draft an article for him that largely mirrored one that appeared under his name on Forbes’s website in 2015. Forbes removed the story from its website on Wednesday and said that it ended its relationship with Mr. Miller amid the revelations.”

The emails between Miller and Monsanto’s Eric Sachs show how corporations and writers sometimes work together to promote corporate talking points in ways that are not disclosed to editors or the public.

In the emails, Sachs asked Miller to write about the decision by the World Health Organization’s International Agency for Research on Cancer (IARC) to classify glyphosate as a probable human carcinogen. Miller replied, “I would be if I could start from a high-quality draft.” Sachs provided what he called a “still quite rough” draft, which he described to Miller as “a good start for your magic.” The draft appeared a few days later, largely unchanged, in this Forbes column that appeared under Miller’s name.

Retraction Watch quoted Mia Carbonell, senior VP of global communications at Forbes, on why Forbes has removed Miller’s work from its site:

“All contributors to Forbes.com sign a contract requiring them to disclose any potential conflicts of interest and only publish content that is their own original writing.  When it came to our attention that Mr. Miller violated these terms, we removed all of his posts from Forbes.com and ended our relationship with him.”

Forbes also removed articles co-bylined by Miller and allies including Julie Kelly, Kavin Senapathy and Bruce Chassy – all of whom have claimed independence while writing in defense of pesticides and GMOs.

Project Syndicate has added this editor’s note to the top of articles written by Miller:

Legitimate objections have been raised about the independence and integrity of the commentaries that Henry Miller has written for Project Syndicate and other outlets; in particular that Monsanto, rather than Miller, drafted some of them. Readers should be aware of this potential conflict of interest, which, had it been known at the time Miller’s commentaries were accepted, would have constituted grounds for rejecting them.

Funding and pitching his PR services

The Hoover Institution, where Miller resides as a fellow, has received funding from corporations and industry groups, including Exxon Mobil and the American Chemistry Council, as well as right-wing foundations — Sarah Scaife Foundation, Searle Freedom Trust, Lynde and Harry Bradley Foundation, Charles Koch Foundation, Donors Trust – and other leading funders of climate science denial that also push deregulation across the economy.

Miller pitched his corporate PR services in a 1998 “Work Plan Promoting Sound Science in Health, Environmental and Biotechnology Policy.” The document, posted in the UCSF Tobacco Industry Documents Library, describes Miller’s fees for writing articles, $5,000-$15,000, and proposed an expanded “science and risk communication” program to include arranging speeches, improving web presence and publishing a book. (Source: «Monsanto Papers»: la bataille de l’information, by Stéphane Foucart and Stéphane Horel in Le Monde, June 2, 2017.)

Friend and trustee of corporate front group ACSH

Miller is a “friend and longtime trustee” of the American Council on Science and Health, and he has also been described as a “director” of that group. ACSH is a corporate front group that pitches its services to corporations for product defense, according to a 2012 leaked financial plan.

Defending the tobacco industry

In a 1994 APCO Associates PR strategy memo to help Phillip Morris organize a global campaign to fight tobacco regulations, Henry Miller was referred to as “a key supporter” of these pro-tobacco industry efforts.

In 2012, Miller wrote that “nicotine … is not particularly bad for you in the amounts delivered by cigarettes or smokeless products.”

Denying climate change

Miller is a member of the “scientific advisory board” of the George C. Marshall Institute, which is famous for its oil and gas industry funded denials of climate change.

Claiming nuclear radiation exposure may be “good for you”

In 2011, after the Japanese tsunami and radiation leaks at the Fukushima nuclear power plants, Miller argued in Forbes that “those … who were exposed to low levels of radiation could have actually benefitted from it.” He asked in Project Syndicate, “Can radiation be good for you?

Defending the pesticide industry 

Miller defended the use of widely-criticized neonicotinoid pesticides and claimed in the Wall Street Journal that “the reality is that honeybee populations are not declining.”

Miller has repeatedly argued for the re-introduction of DDT, a toxic pesticide banned in the United States since 1972, which has been linked to pre-term birth and fertility impairment in women.

Attacking the organic industry

Miller’s recent activities include numerous attacks on the organic industry, including “The Colossal Hoax of Organic Agriculture” (Forbes), “Organic Farming is Not Sustainable” (Wall Street Journal) and “The Dirty Truth About Organic Produce” (Newsweek).

In May 2017, Miller claimed, “Organic agriculture is to the environment what cigarette smoking is to human health.”

Defending the plastics industry

Miller defended the endocrine disruptor bisphenol A (BPA), which is banned in Europe and Canada for use in baby bottles.

Miller’s prolific pro-industry writings include

Jayson Lusk and Henry I. Miller, “We Need G.M.O. Wheat.” New York Times, February 2, 2014. Henry I. Miller and Gregory Conko, “General Mills Has a Soggy Idea for Cheerios.” Wall Street Journal, January 20, 2014. Henry I. Miller, “India’s GM Food Hypocrisy.” Wall Street Journal, November 28, 2012. Henry I. Miller, “Organic Farming Is Not Sustainable.” Wall Street Journal, May 15, 2014. Henry I. Miller, “More Crop for the Drop.” Project Syndicate, August 7, 2014. Henry Miller, “California’s Anti-GMO Hysteria.” National Review, March 31, 2014. Henry I. Miller, “Genetic Engineering and the Fight Against Ebola.” Wall Street Journal, August 25, 2014. Henry I. Miller, “Salmon Label Bill Should Be Thrown Back.” Orange County Register, April 4, 2011. Henry I. Miller, “GE Labels Mean Higher Costs.” San Francisco Chronicle, September 7, 2012. Gregory Conko and Henry Miller, “Labeling Of Genetically Engineered Foods Is a Losing Proposition.” Forbes, September 12, 2012. Gregory Conko and Henry I. Miller, “A Losing Proposition on Food Labeling.” Orange County Register, October 11, 2012. Henry I. Miller and Bruce Chassy, “Scientists Smell A Rat In Fraudulent Genetic Engineering Study.” Forbes, September 25, 2012. Jay Byrne and Henry I. Miller, “The Roots of the Anti-Genetic Engineering Movement? Follow the Money!Forbes, October 22, 2012.

Miller articles removed from Forbes include: Henry I. Miller and Julie Kelly, “How Organic Agriculture Evolved from Marketing Tool to Evil Empire,” Forbes, Dec. 2, 2015; Henry I. Miller and Julie Kelly, “Federal Subsidies to Organic Agriculture Should be Plowed Under,” Forbes, July 12, 2017;  Henry I. Miller and Julie Kelly, “Government Favors and Subsidies to Organic Agriculture: Follow the Money,” Forbes, Sept. 23, 2015.

Articles About Miller 

“Some GMO Cheerleaders Also Deny Climate Change” — Mother Jones

“Pro-Science GMO and Chemical Boosters Funded by Climate Deniers” – The Ecologist

“DDT and Malaria: Setting the Record Straight” – Pesticide Action Network

“TV Ad Against Food Labeling Initiative is Pulled” – Los Angeles Times

“Stanford Ad Demands Anti-Prop 37 Ad Be Changed” – Palo Alto News

Chemical Industry Allies

USRTK has compiled a series of fact sheets about writers and PR groups the agrichemical industry relies on to manufacture doubt about science that raises concern about risky products and argue against environmental health protections.
– Why You Can’t Trust Henry I. Miller
Why Forbes Deleted Some Kavin Senapathy Articles
Julie Kelly Cooks up Propaganda for the Chemical Industry
– The American Council on Science and Health is  Corporate Front Group
– Jon Entine of Genetic Literacy Project: The Chemical Industry’s Master Messenger
– Trevor Butterworth / Sense About Science Spins Science for Industry
Does Science Media Centre Push Corporate Views of Science?

Follow the USRTK investigation of Big Food and its front groups: https://usrtk.org/our-investigations/

Collusion or Coincidence? Records Show EPA Efforts to Slow Herbicide Review Came in Coordination with Monsanto

Print Email Share Tweet

Newly released government email communications show a persistent effort by multiple officials within the Environmental Protection Agency (EPA) to slow a separate federal agency’s safety review of Monsanto’s top-selling herbicide. Notably, the records demonstrate that the EPA efforts came at the behest of Monsanto, and that EPA officials were helpful enough to keep the chemical giant updated on their progress.

The communications, most of which were obtained through Freedom of Information Act (FOIA) requests, show that it was early 2015 when the EPA and Monsanto began working in concert to stall a toxicology review that a unit tied to the Centers for Disease Control and Prevention (CDC) was conducting on glyphosate, the key ingredient in Monsanto’s branded Roundup herbicide products. The details revealed in the documents come as Monsanto is defending itself against lawsuits alleging that it has tried to cover up evidence of harm with its herbicides.

The Agency for Toxic Substances and Disease Registry (ATSDR), a federal public health agency that along with the CDC is part of the U.S. Department of Health and Human Services (HHS), is charged with evaluating the potential adverse human health effects from exposures to hazardous substances in the environment. So it made sense for the ATSDR to take a look at glyphosate, which is widely used on U.S. farms, residential lawns and gardens, school playgrounds and golf courses. Glyphosate is widely used in food production and glyphosate residues have been found in testing of human urine.

The ATSDR announced in February 2015 that it planned to publish a toxicological profile of glyphosate by October of that year. But by October, that review was on hold, and to this date no such review has yet been published.

The documents reveal this was no accident, no bureaucratic delay, but rather was the result of a collaborative effort between Monsanto and a group of high-ranking EPA officials.

For Monsanto, the timing of the ATSDR review was worrisome. In March 2015, the World Health Organization’s International Agency for Research on Cancer (IARC) had declared glyphosate to be a probable human carcinogen, and Monsanto feared ATSDR might have similar concerns about the chemical. Previous reports have described how one EPA official, Jess Rowland, communicated to Monsanto in April 2015 his willingness to try to kill the ATSDR review. Rowland, who retired in 2016, was the deputy division director within the health effects division of the EPA’s Office of Pesticide Programs (OPP). Allegations of collusion between Rowland and Monsanto have prompted a probe by the EPA’s Office of Inspector General.

But the trove of documents newly obtained from within EPA and HHS demonstrate that the assistance to Monsanto came not only from Rowland but also from even higher-level EPA officials. Rather than encourage and assist the toxicology review of glyphosate, Monsanto and EPA officials repeatedly complained to ATSDR and HHS that such a review was unnecessarily “duplicative” and should take a back seat to an EPA review also underway.

The following timeline shows how the events unfolded:

May 19, 2015 – Michael Dykes, who at that time was Monsanto’s long-time vice president of government affairs, wrote directly to the EPA’s Jim Jones, the Assistant Administrator for the Office of Chemical Safety & Pollution Prevention. Jones had oversight of the EPA’s Office of Pesticide Programs (OPP) and was a presidential appointee who carried significant clout. The afternoon was waning when the email came in at 3:28 p.m. Dykes reminded Jones that they had recently discussed the HHS’ ATSDR glyphosate review at a meeting. “You were not aware of their review. Did you learn anything more about their efforts?” Dykes asked.

Jones did not waste time. Roughly an hour later he forwarded the message to OPP Director Jack Housenger, writing “Monsanto thinks atsdr is doing a glyphosate Assessment. Could you guys run that down?” Housenger responds quickly: “Yes. Jess checked with them…. It has been difficult to get information.”

Within an hour Jones instructed a member of his staff to get him contact information for the head person responsible for ATSDR. She replied the next morning that Dr. Patrick Breysse was the point person. Breysse joined the CDC in 2014 as director of its National Center for Environmental Health, overseeing the NCEH’s ATSDR.

May 20, 2015 It was only a little after 8:30 a.m. but Jones told the staff member to instruct Housenger to get in touch with Breysse, and within two hours Housenger had penned an email to Breysse explaining that an EPA’s own re-evaluation/risk assessment of glyphosate was nearing completion, and asking Breysse if “you would still feel the need to do your assessment.” Housenger told Breysse that he already had reached the individual assigned to the ATSDR assessment and she had indicated she would “coordinate” with EPA, but that was not sufficient. Housenger did not mention Monsanto’s outreach to EPA on the issue, but instead questioned “whether this is a good use of government resources” for ATSDR to continue with its review. Breysse responded that he would “look into this” and Housenger thanked him for his quick response. Breysse then reached out to an ATSDR division director named James Stephens to arrange a discussion about the EPA request.

May 21, 2015 James Stephens wrote back to Patrick Breysse that the ATSDR team thought the EPA work “overlaps but isn’t totally duplicative…” and stated that the ASTDR team has not been able to see draft copies of the EPA’s work. “I think we would all welcome further discussion with EPA but would hope to use it to help us find out more about what they are doing, ” he told Breysse. After hearing from Stephens, Breysse wrote back to Housenger saying ATSDR staff would be in touch to discuss. Housenger replied with his reiteration that the ATSDR review would be a “duplicative government effort” and that the EPA draft would be out in July of 2015. (As of this writing, that EPA preliminary risk assessment still has not been released, though in 2016 the EPA did release a cancer assessment report that declared glyphosate was not likely to cause cancer.)

June 4, 2015 Pressing the issue, EPA’s Housenger wrote again to Breysee to say he had not heard from anyone yetThe ATSDR’s Stephens wrote back promising to make sure “someone gives you a ring.” Internal Monsanto emails show that at the same time, Monsanto was also pushing the “duplicative” narrative with HHS, meeting on June 4 with HHS Deputy Assistant Secretary for Global Health Mitchel Wolfe to ask him to help repudiate the IARC classification and to recognize that a review of glyphosate was “not the primary role” for his agency. “Dr. Wolfe said he would follow up on what was going on with ATSDR and he was encouraged to have discussions with EPA staff, as well,” a Monsanto memo detailing the meeting states.

June 9, 2015 Henry Abadin, an ATSDR supervisory scientist, reported to Stephens that he had talked with Housenger and explained that the agency did not believe it was “duplicating efforts.” Nevertheless, he said he told EPA, “we did not have a problem with putting the glyphosate profile on hold, pending the OPP final report.”

June 19, 2015 To further ensure the ATSDR review didn’t move forward, Monsanto’s Dykes talked again with HHS’s Wolfe, asking for an update on ATSDR. “I explained… our question was about the purpose and scope of such a duplicative review by ATSDR. I also told him that we were concerned that ATSDR may come out any day with a report. I again stressed that we were concerned that they were even reviewing glyphosate as were the people we talked with at EPA,” Dykes wrote to colleagues.

June 21, 2015 It was a Sunday, but Monsanto’s Dykes was still concerned enough about the ATSDR review to copy multiple colleagues on a late night email to report that he had continued to press the “duplicative” point with ATSDR but was concerned about a “glyphosate review coming any day.” In a text message sent that same day, Monsanto scientist Eric Sachs reached out to a former EPA toxicologist named Mary Manibusan asking for contacts at ATSDR. “We’re trying to do everything we can to keep from having a domestic IARC occur w this group. may need your help,” Sachs wrote. The text messages were among certain internal Monsanto records obtained by cancer victims who are suing Monsanto alleging Roundup caused their diseases.

June 23, 2015 By Tuesday, Monsanto’s Jenkins had good news: He had heard from Housenger that the EPA official had been successful in garnering a promise from ATSDR to put its report “on hold.” The review was not dead, however, he wrote: ATSDR argues “that their process is distinguishable and not duplicative. They look at different endpoints and told EPA they don’t “make a call on cancer”, but I think we should continue to be cautious.”

On June 24, 2015 Monsanto’s chief scientist William Heydens responded:“’Distinguishable and not duplicative’? Seriously? And I will believe the not ‘making a call on cancer’ part when I see it. Anyway, at least they know they are being watched, and hopefully that keeps them from doing anything too stupid…” Jenkins wrote back, acknowledging that Monsanto had much more to fear from ATSDR than EPA as the two agencies had arrived at “different conclusions” on other issues. He reported he had been told ATSDR was “VERY conservative and IARC like…”

By October 23, 2015 EPA and Monsanto had the ATSDR review fully on hold. EPA’s Housenger wrote to update Monsanto’s Jenkins: “They are waiting for our glyphosate RA. And they agreed to share what they do.”

That same month, the EPA’s Cancer Assessment Review Committee (CARC), which was chaired by Rowland, issued an internal report stating that contrary to IARC, the EPA’s review of glyphosate found it “not likely to be carcinogenic to humans.”

The EPA still has yet to issue the overall new risk assessment it said would be out in 2015. The agency has offered ever-changing timelines for the assessment, but now says its intends to release a draft risk assessment sometime this year. That will be followed by a 60-day public comment period. After the public comment period the EPA will determine whether any risk management is needed. In the meantime, Monsanto has cited the EPA’s backing of glyphosate safety as repudiation of the IARC finding both in court and with regulators in Europe who are also looking at glyphosate safety issues.

The EPA did not respond to a request for comment about its efforts to delay the ATSDR report or communications with Monsanto regarding that effort.

But Brent Wisner, a lawyer representing many of the cancer victims who are suing Monsanto, said the documents offer damning evidence of improperly close ties between the EPA and the chemical company.

“I think it’s very clear… that EPA officials and Monsanto employees worked together to accomplish a goal of stopping that analysis at ATSDR. That is collusion. I don’t know what else you’d call that,” said Wisner.

For its part, the ATSDR said this week that the review it started in 2015 “is not complete” but that it anticipates a draft glyphosate toxicological profile to be issued for public comment by the end of this year. A spokesperson for the agency declined to discuss the circumstances surrounding the delay in the review.

And Jones, whose EPA job ended when the Trump administration took over, defended his responsiveness to Monsanto’s concern about the ATSDR review, saying it had only to do with the “efficient use of government resources.”

“Had any party contacted me and informed me that another agency within the Administration was simultaneously assessing a chemical as my organization, I would have intervened,” Jones said. “There is no value to the same government investing limited resources to work on the same issue. As you know resources at the federal level were and are scarce which made duplication even more problematic.” Jones said additionally that “when two organizations assess the same chemical, it is very likely there will be differences in their assessments. Even when these differences don’t matter from a public health perspective, an enormous amount of energy is spent attempting to resolve these differences” and that is not ultimately in the “public interest.”

Aspartame: Decades of Science Point to Serious Health Risks

Print Email Share Tweet

Long History of Concerns
Key Scientific Studies on Aspartame
Industry PR Efforts
Scientific References

Key Facts About Diet Soda Chemical 

What is Aspartame?

  • Aspartame is the world’s most widely used artificial sweetener. It is also marketed as NutraSweet, Equal, Sugar Twin and AminoSweet.
  • Aspartame is present in more than 6,000 products, including Diet Coke and Diet Pepsi, Kool Aid, Crystal Light, Tango and other artificially sweetened drinks; sugar-free Jell-O products; Trident, Dentyne and most other brands of sugar-free gum; sugar-free hard candies; low- or no-sugar sweet condiments such as ketchups and dressings; children’s medicines, vitamins and cough drops.
  • Aspartame is a synthetic chemical composed of the amino acids phenylalanine and aspartic acid, with a methyl ester. When consumed, the methyl ester breaks down into methanol, which may be converted into formaldehyde.

Decades of Studies Raise Concerns about Aspartame

Since aspartame was first approved in 1974, both FDA scientists and independent scientists have raised concerns about possible health effects and shortcomings in the science submitted to the FDA by the manufacturer, G.D. Searle. (Monsanto bought Searle in 1984).

In 1987, UPI published a series of investigative articles by Gregory Gordon reporting on these concerns, including early studies linking aspartame to health problems, the poor quality of industry-funded research that led to its approval, and the revolving-door relationships between FDA officials and the food industry. Gordon’s series is an invaluable resource for anyone seeking to understand the history of aspartame/NutraSweet:

Health Effects and Key Studies on Aspartame 

While many studies, some of them industry sponsored, have reported no problems with aspartame, dozens of independent studies conducted over decades have linked aspartame to a long list of health problems, including:

Cancer

In the most comprehensive cancer research to date on aspartame, three lifespan studies conducted by the Cesare Maltoni Cancer Research Center of the Ramazzini Institute, provide consistent evidence of carcinogenicity in rodents exposed to the substance.

  • Aspartame “is a multipotential carcinogenic agent, even at a daily dose of … much less than the current acceptable daily intake,” according to a 2006 lifespan rat study in Environmental Health Perspectives.1
  • A follow-up study in 2007 found significant dose-related increases in malignant tumors in some of the rats. “The results … confirm and reinforce the first experimental demonstration of [aspartame’s] multipotential carcinogenicity at a dose level close to the acceptable daily intake for humans … when life-span exposure begins during fetal life, its carcinogenic effects are increased,” the researchers wrote in Environmental Health Perspectives.2
  • The results of a 2010 lifespan study “confirm that [aspartame] is a carcinogenic agent in multiple sites in rodents, and that this effect is induced in two species, rats (males and females) and mice (males),” the researchers reported in American Journal of Industrial Medicine.3

Harvard researchers in 2012 reported a positive association between aspartame intake and increased risk of non-Hodgkin lymphoma and multiple myeloma in men, and for leukemia in men and women. The findings “preserve the possibility of a detrimental effect … on select cancers” but “do not permit the ruling out of chance as an explanation,” the researchers wrote in the American Journal of Clinical Nutrition.4

In a 2014 commentary in American Journal of Industrial Medicine, the Maltoni Center researchers wrote that the studies submitted by G. D. Searle for market approval “do not provide adequate scientific support for [aspartame’s] safety. In contrast, recent results of life-span carcinogenicity bioassays on rats and mice published in peer-reviewed journals, and a prospective epidemiological study, provide consistent evidence of [aspartame’s] carcinogenic potential. On the basis of the evidence of the potential carcinogenic effects … a re-evaluation of the current position of international regulatory agencies must be considered an urgent matter of public health.”5

Brain Tumors

In 1996, researchers reported in the Journal of Neuropathology & Experimental Neurology on epidemiological evidence connecting the introduction of aspartame to an increase in an aggressive type of malignant brain tumors. “Compared to other environmental factors putatively linked to brain tumors, the artificial sweetener aspartame is a promising candidate to explain the recent increase in incidence and degree of malignancy of brain tumors … We conclude that there is need for reassessing the carcinogenic potential of aspartame.”6

  • Neuroscientist Dr. John Olney, lead author of the study, told 60 minutes in 1996: “there has been a striking increase in the incidence of malignant brain tumors (in the three to five years following the approval of aspartame) … there is enough basis to suspect aspartame that it needs to be reassessed. FDA needs to reassess it, and this time around, FDA should do it right.”

Early studies on aspartame in the 1970s found evidence of brain tumors in laboratory animals, but those studies were not followed up.

Cardiovascular Disease 

A 2017 meta-analysis of research on artificial sweeteners, published in the Canadian Medical Association Journal, found no clear evidence of weight loss benefits for artificial sweeteners in randomized clinical trials, and reported that cohort studies associate artificial sweeteners with “increases in weight and waist circumference, and higher incidence of obesity, hypertension, metabolic syndrome, type 2 diabetes and cardiovascular events.”7

  • See also: “Artificial sweeteners don’t help with weight loss and may lead to gained pounds,” by Catherine Caruso, STAT (7.17.2017)

 A 2016 paper in Physiology & Behavior reported, “there is a striking congruence between results from animal research and a number of large-scale, long-term observational studies in humans, in finding significantly increased weight gain, adiposity, incidence of obesity, cardiometabolic risk, and even total mortality among individuals with chronic, daily exposure to low-calorie sweeteners – and these results are troubling.”8

Women who consumed more than two diet drinks per day “had a higher risk of [cardiovascular disease] events … [cardiovascular disease] mortality … and overall mortality,” according to a 2014 study from the Women’s Health Initiative published in the Journal of General Internal Medicine.9

Stroke, Dementia and Alzheimer’s Disease

People drinking diet soda daily were almost three times as likely to develop stroke and dementia as those who consumed it weekly or less. This included a higher risk of ischemic stroke, where blood vessels in the brain become obstructed, and Alzheimer’s disease dementia, the most common form of dementia, reported a 2017 study in Stroke.10

In the body, the methyl ester in aspartame metabolizes into methanol and then it may be converted to formaldehyde, which has been linked to Alzheimer’s disease. A two-part study published in 2014 in the Journal of Alzheimer’s Disease linked chronic methanol exposure to memory loss and Alzheimer’s Disease symptoms in mice and monkeys.

  • “[M]ethanol-fed mice presented with partial AD-like symptoms … These findings add to a growing body of evidence that links formaldehyde to [Alzheimer’s disease] pathology.” (Part 1)11
  • “[M]ethanol feeding caused long-lasting and persistent pathological changes that were related to [Alzheimer’s disease] … these findings support a growing body of evidence that links methanol and its metabolite formaldehyde to [Alzheimer’s disease] pathology.” (Part 2)12

Seizures

“Aspartame appears to exacerbate the amount of EEG spike wave in children with absence seizures. Further studies are needed to establish if this effect occurs at lower doses and in other seizure types,” according to a 1992 study in Neurology.13

Aspartame “has seizure-promoting activity in animal models that are widely used to identify compounds affecting … seizure incidence,” according to a 1987 study in Environmental Health Perspectives.14

Very high aspartame doses “might also affect the likelihood of seizures in symptomless but susceptible people,” according to a 1985 study in The Lancet. The study describes three previously healthy adults who had grand mal seizures during periods when they were consuming high doses of aspartame.15

Neurotoxicity, Brain Damage and Mood Disorders

Aspartame has been linked to behavioral and cognitive problems including learning problems, headache, seizure, migraines, irritable moods, anxiety, depression, and insomnia, wrote the researchers of a 2017 study in Nutritional Neuroscience. “Aspartame consumption needs to be approached with caution due to the possible effects on neurobehavioral health.”16

“Oral aspartame significantly altered behavior, anti-oxidant status and morphology of the hippocampus in mice; also, it may probably trigger hippocampal adult neurogenesis,” reported a 2016 study in Neurobiology of Learning and Memory.17 

“Previously, it has been reported that consumption of aspartame could cause neurological and behavioural disturbances in sensitive individuals. Headaches, insomnia and seizures are also some of the neurological effects that have been encountered,” according to a 2008 study in the European Journal of Clinical Nutrition. “[W]e propose that excessive aspartame ingestion might be involved in the pathogenesis of certain mental disorders … and also in compromised learning and emotional functioning.”18 

“(N)eurological symptoms, including learning and memory processes, may be related to the high or toxic concentrations of the sweetener [aspartame] metabolites,” states a 2006 study in Pharmacological Research.19

Aspartate “could impair memory retention and damage hypothalamic neurons in adult mice,” according to a 2000 mice study published in Toxicology Letters.20

“(I)ndividuals with mood disorders are particularly sensitive to this artificial sweetener and its use in this population should be discouraged,” according to a 1993 study in the Journal of Biological Psychiatry.21

High doses of aspartame “can generate major neurochemical changes in rats,” reported a 1984 study in American Journal of Clinical Nutrition.22

Experiments indicated brain damage in infant mice following oral intake of aspartate, and showing that “aspartate [is] toxic to the infant mouse at relatively low levels of oral intake,” reported a 1970 study in Nature.23

Headaches and Migraines

“Aspartame, a popular dietetic sweetener, may provoke headache in some susceptible individuals. Herein, we describe three cases of young women with migraine who reported their headaches could be provoked by chewing sugarless gum containing aspartame,” according to a 1997 paper in Headache Journal.24

A crossover trial comparing aspartame and a placebo published in 1994 in Neurology, “provides evidence that, among individuals with self-reported headaches after ingestion of aspartame, a subset of this group report more headaches when tested under controlled conditions. It appears that some people are particularly susceptible to headaches caused by aspartame and may want to limit their consumption.”25

A survey of 171 patients at the Montefiore Medical Center Headache Unit found that patients with migraine “reported aspartame as a precipitant three times more often than those having other types of headache … We conclude aspartame may be an important dietary trigger of headache in some people,” 1989 study in Headache Journal.26

A crossover trial comparing aspartame and a placebo on the frequency and intensity of migraines “indicated that the ingestion of aspartame by migraineurs caused a significant increase in headache frequency for some subjects,” reported a 1988 study in Headache Journal.27

Kidney Function Decline

Consumption of more than two servings a day of artificially sweetened soda “is associated with a 2-fold increased odds for kidney function decline in women,” according to a 2011 study in the Clinical Journal of American Society of Nephrology.28

Weight Gain, Increased Appetite and Obesity Related Problems

Several studies link aspartame to weight gain, increased appetite, diabetes, metabolic derangement and obesity-related diseases. See our fact sheet: Diet Soda Chemical Tied to Weight Gain.

This science linking aspartame to weight gain and obesity-related diseases raises questions about the legality of marketing aspartame-containing products as “diet” or weight loss aids. In 2015, USRTK petitioned the Federal Trade Commission and FDA to investigate the marketing and advertising practices of “diet” products that contain a chemical linked to weight gain. See related news coverage, response from FTC, and response from FDA.

Diabetes and Metabolic Derangement

Aspartame breaks down in part into phenylalanine, which interferes with the action of an enzyme intestinal alkaline phosphatase (IAP) previously shown to prevent metabolic syndrome (a group of symptoms associated with type 2 diabetes and cardiovascular disease) according to a 2017 study in Applied Physiology, Nutrition and Metabolism. In this study, mice receiving aspartame in their drinking water gained more weight and developed other symptoms of metabolic syndrome than animals fed similar diets lacking aspartame. The study concludes, “IAP’s protective effects in regard to the metabolic syndrome may be inhibited by phenylalanine, a metabolite of aspartame, perhaps explaining the lack of expected weight loss and metabolic improvements associated with diet drinks.”29

People who regularly consume artificial sweeteners are at increased risk of “excessive weight gain, metabolic syndrome, type 2 diabetes, and cardiovascular disease,” according to a 2013 Purdue review over 40 years published in Trends in Endocrinology & Metabolism.30

In a study that followed 66,118 women over 14 years, both sugar-sweetened beverages and artificially sweetened beverages were associated with risk of Type 2 diabetes. “Strong positive trends in T2D risk were also observed across quartiles of consumption for both types of beverage … No association was observed for 100% fruit juice consumption,” reported the 2013 study published in American Journal of Clinical Nutrition.31

Intestinal Dysbiosis, Metabolic Derangement and Obesity

Artificial sweeteners can induce glucose intolerance by altering the gut microbiota, according to a 2014 study in Nature. The researchers wrote, “our results link NAS [non-caloric artificial sweetener] consumption, dysbiosis and metabolic abnormalities, thereby calling for a reassessment of massive NAS usage … Our findings suggest that NAS may have directly contributed to enhancing the exact epidemic [obesity] that they themselves were intended to fight.”32

A 2016 study in Applied Physiology Nutrition and Metabolism reported, “Aspartame intake significantly influenced the association between body mass index (BMI) and glucose tolerance… consumption of aspartame is associated with greater obesity-related impairments in glucose tolerance.”33

According to a 2014 rat study in PLoS ONE, “aspartame elevated fasting glucose levels and an insulin tolerance test showed aspartame to impair insulin-stimulated glucose disposal … Fecal analysis of gut bacterial composition showed aspartame to increase total bacteria…”34

 Pregnancy Abnormalities: Pre Term Birth 

According to a 2010 cohort study of 59,334 Danish pregnant women published in the American Journal of Clinical Nutrition, “There was an association between intake of artificially sweetened carbonated and noncarbonated soft drinks and an increased risk of preterm delivery.” The study concluded, “Daily intake of artificially sweetened soft drinks may increase the risk of preterm delivery.”35

  • See also: “Downing Diet Soda Tied to Premature Birth,” by Anne Harding, Reuters (7.23.2010)

Overweight Babies

Artificially sweetened beverage consumption during pregnancy is linked to higher body mass index for babies, according to a 2016 study in JAMA Pediatrics. “To our knowledge, we provide the first human evidence that maternal consumption of artificial sweeteners during pregnancy may influence infant BMI,” the researchers wrote.36

Early Menarche

The National Heart, Lung, and Blood Institute Growth and Health Study followed 1988 girls for 10 years to examine prospective associations between consumption of caffeinated and noncaffeinated sugar- and artificially sweetened soft drinks and early menarche. “Consumption of caffeinated and artificially sweetened soft drinks was positively associated with risk of early menarche in a US cohort of African American and Caucasian girls,” concluded the study published in 2015 in Journal of American Clinical Nutrition.37

Sperm Damage

“A significant decrease in sperm function of aspartame treated animals was observed when compared with the control and MTX control,” according to a 2017 study in the International Journal of Impotence Research. “… These findings demonstrate that aspartame metabolites could be a contributing factor for development of oxidative stress in the epididymal sperm.”38

Liver Damage and Glutathione Depletion

A mouse study published in 2017 in Redox Biology reported, “Chronic administration of aspartame … caused liver injury as well as marked decreased hepatic levels of reduced glutathione, oxidized glutathione, γ-glutamylcysteine, and most metabolites of the trans-sulphuration pathway…”39

A rat study published in 2017 in Nutrition Research found that, “Subchronic intake of soft drink or aspartame substantially induced hyperglycemia and hypertriacylglycerolemia… Several cytoarchitecture alterations were detected in the liver, including degeneration, infiltration, necrosis, and fibrosis, predominantly with aspartame. These data suggest that long-term intake of soft drink or aspartame-induced hepatic damage may be mediated by the induction of hyperglycemia, lipid accumulation, and oxidative stress with the involvement of adipocytokines.”40

Caution for Vulnerable Populations

A 2016 literature review on artificial sweeteners in the Indian Journal of Pharmacology reported, “there is inconclusive evidence to support most of their uses and some recent studies even hint that these earlier established benefits … might not be true.” Susceptible populations such as pregnant and lactating women, children, diabetics, migraine, and epilepsy patients “should use these products with utmost caution.”41

Industry PR Efforts and Front Groups 

From the start, G.D. Searle (later Monsanto and the NutraSweet Company) deployed aggressive PR tactics to market aspartame as a safe product. In October 1987, Gregory Gordon reported in UPI:

“The NutraSweet Co. also has paid up to $3 million a year for a 100-person public relations effort by the Chicago offices of Burson Marsteller, a former employee of the New York PR firm said. The employee said Burson Marsteller has hired numerous scientists and physicians, often at $1,000 a day, to defend the sweetener in media interviews and other public forums. Burson Marsteller declines to discuss such matters.”

Recent reporting based on internal industry documents reveals how beverage companies such as Coca-Cola also pay third party messengers, including doctors and scientists, to promote their products and shift the blame when science ties their products to serious health problems.

See reporting by Anahad O’Connor in the New York Times, Candice Choi in the Associated Press, and findings from the USRTK investigation about sugar industry propaganda and lobbying campaigns.

News articles about soda industry PR campaigns:

Overview news stories about aspartame:

USRTK Fact Sheets

Reports on Front Groups and PR Campaigns

Scientific References

[1] Soffritti M, Belpoggi F, Degli Esposti D, Lambertini L, Tibaldi E, Rigano A. “First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed to Sprague-Dawley rats.” Environ Health Perspect. 2006 Mar;114(3):379-85. PMID: 16507461. (article)

[2] Soffritti M, Belpoggi F, Tibaldi E, Esposti DD, Lauriola M. “Life-span exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats.” Environ Health Perspect. 2007 Sep;115(9):1293-7. PMID: 17805418. (article)

[3] Soffritti M et al. “Aspartame administered in feed, beginning prenatally through life span, induces cancers of the liver and lung in male Swiss mice.” Am J Ind Med. 2010 Dec; 53(12):1197-206. PMID: 20886530. (abstract / article)

[4] Schernhammer ES, Bertrand KA, Birmann BM, Sampson L, Willett WC, Feskanich D., “Consumption of artificial sweetener– and sugar-containing soda and risk of lymphoma and leukemia in men and women.” Am J Clin Nutr. 2012 Dec;96(6):1419-28. PMID: 23097267. (abstract / article)

[5] Soffritti M1, Padovani M, Tibaldi E, Falcioni L, Manservisi F, Belpoggi F., “The carcinogenic effects of aspartame: The urgent need for regulatory re-evaluation.” Am J Ind Med. 2014 Apr;57(4):383-97. doi: 10.1002/ajim.22296. Epub 2014 Jan 16. (abstract / article)

[6] Olney JW, Farber NB, Spitznagel E, Robins LN. “Increasing brain tumor rates: is there a link to aspartame?” J Neuropathol Exp Neurol. 1996 Nov;55(11):1115-23. PMID: 8939194. (abstract)

[7] Azad, Meghan B., et al. Nonnutritive sweeteners and cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials and prospective cohort studies. CMAJ July 17, 2017 vol. 189 no. 28 doi: 10.1503/cmaj.161390 (abstract / article)

[8] Fowler SP. Low-calorie sweetener use and energy balance: Results from experimental studies in animals, and large-scale prospective studies in humans. Physiol Behav. 2016 Oct 1;164(Pt B):517-23. doi: 10.1016/j.physbeh.2016.04.047. Epub 2016 Apr 26. (abstract)

[9] Vyas A et al. “Diet Drink Consumption And The Risk of Cardiovascular Events: A Report from The Women’s Health Initiative.” J Gen Intern Med. 2015 Apr;30(4):462-8. doi: 10.1007/s11606-014-3098-0. Epub 2014 Dec 17. (abstract / article)

[10] Matthew P. Pase, PhD; Jayandra J. Himali, PhD; Alexa S. Beiser, PhD; Hugo J. Aparicio, MD; Claudia L. Satizabal, PhD; Ramachandran S. Vasan, MD; Sudha Seshadri, MD; Paul F. Jacques, DSc. “Sugar and Artificially Sweetened Beverages and the Risks of Incident Stroke and Dementia. A Prospective Cohort Study.” Stroke. 2017 April; STROKEAHA.116.016027 (abstract / article)

[11] Yang M et al. “Alzheimer’s Disease and Methanol Toxicity (Part 1): Chronic Methanol Feeding Led to Memory Impairments and Tau Hyperphosphorylation in Mice.” J Alzheimers Dis. 2014 Apr 30. (abstract)

[12] Yang M et al. “Alzheimer’s Disease and Methanol Toxicity (Part 2): Lessons from Four Rhesus Macaques (Macaca mulatta) Chronically Fed Methanol.” J Alzheimers Dis. 2014 Apr 30. (abstract)

[13] Camfield PR, Camfield CS, Dooley JM, Gordon K, Jollymore S, Weaver DF. “Aspartame exacerbates EEG spike-wave discharge in children with generalized absence epilepsy: a double-blind controlled study.” Neurology. 1992 May;42(5):1000-3. PMID: 1579221. (abstract)

[14] Maher TJ, Wurtman RJ. “Possible neurologic effects of aspartame, a widely used food additive.” Environ Health Perspect. 1987 Nov; 75:53-7. PMID: 3319565. (abstract / article)

[15] Wurtman RJ. “Aspartame: possible effect on seizure susceptibility.” Lancet. 1985 Nov 9;2(8463):1060. PMID: 2865529. (abstract)

[16] Choudhary AK, Lee YY. “Neurophysiological symptoms and aspartame: What is the connection?” Nutr Neurosci. 2017 Feb 15:1-11. doi: 10.1080/1028415X.2017.1288340. (abstract)

[17] Onaolapo AY, Onaolapo OJ, Nwoha PU. “Aspartame and the hippocampus: Revealing a bi-directional, dose/time-dependent behavioural and morphological shift in mice.” Neurobiol Learn Mem. 2017 Mar;139:76-88. doi: 10.1016/j.nlm.2016.12.021. Epub 2016 Dec 31. (abstract)

[18] Humphries P, Pretorius E, Naudé H. “Direct and indirect cellular effects of aspartame on the brain.” Eur J Clin Nutr. 2008 Apr;62(4):451-62. (abstract / article)

[19] Tsakiris S, Giannoulia-Karantana A, Simintzi I, Schulpis KH. “The effect of aspartame metabolites on human erythrocyte membrane acetylcholinesterase activity.” Pharmacol Res. 2006 Jan;53(1):1-5. PMID: 16129618. (abstract)

[20] Park CH et al. “Glutamate and aspartate impair memory retention and damage hypothalamic neurons in adult mice.” Toxicol Lett. 2000 May 19;115(2):117-25. PMID: 10802387. (abstract)

[21] Walton RG, Hudak R, Green-Waite R. “Adverse reactions to aspartame: double-blind challenge in patients from a vulnerable population.” J. Biol Psychiatry. 1993 Jul 1-15;34(1-2):13-7. PMID: 8373935. (abstract / article)

[22] Yokogoshi H, Roberts CH, Caballero B, Wurtman RJ. “Effects of aspartame and glucose administration on brain and plasma levels of large neutral amino acids and brain 5-hydroxyindoles.” Am J Clin Nutr. 1984 Jul;40(1):1-7. PMID: 6204522. (abstract)

[23] Olney JW, Ho OL. “Brain Damage in Infant Mice Following Oral Intake of Glutamate, Aspartate or Cysteine.” Nature. 1970 Aug 8;227(5258):609-11. PMID: 5464249. (abstract)

[24] Blumenthal HJ, Vance DA. “Chewing gum headaches.” Headache. 1997 Nov-Dec; 37(10):665-6. PMID: 9439090. (abstract/article)

[25] Van den Eeden SK, Koepsell TD, Longstreth WT Jr, van Belle G, Daling JR, McKnight B. “Aspartame ingestion and headaches: a randomized crossover trial.” Neurology. 1994 Oct;44(10):1787-93. PMID: 7936222. (abstract)

[26] Lipton RB, Newman LC, Cohen JS, Solomon S. “Aspartame as a dietary trigger of headache.” Headache. 1989 Feb;29(2):90-2. PMID: 2708042. (abstract)

[27] Koehler SM, Glaros A. “The effect of aspartame on migraine headache.” Headache. 1988 Feb;28(1):10-4. PMID: 3277925. (abstract)

[28] Julie Lin and Gary C. Curhan. “Associations of Sugar and Artificially Sweetened Soda with Albuminuria and Kidney Function Decline in Women.” Clin J Am Soc Nephrol. 2011 Jan; 6(1): 160–166. (abstract / article)

[29] Gul SS, Hamilton AR, Munoz AR, Phupitakphol T, Liu W, Hyoju SK, Economopoulos KP, Morrison S, Hu D, Zhang W, Gharedaghi MH, Huo H, Hamarneh SR, Hodin RA. “Inhibition of the gut enzyme intestinal alkaline phosphatase may explain how aspartame promotes glucose intolerance and obesity in mice.” Appl Physiol Nutr Metab. 2017 Jan;42(1):77-83. doi: 10.1139/apnm-2016-0346. Epub 2016 Nov 18. (abstract / article)

[30] Susan E. Swithers, “Artificial sweeteners produce the counterintuitive effect of inducing metabolic derangements.” Trends Endocrinol Metab. 2013 Sep; 24(9): 431–441. (article)

[31] Guy Fagherazzi, A Vilier, D Saes Sartorelli, M Lajous, B Balkau, F Clavel-Chapelon. “Consumption of artificially and sugar-sweetened beverages and incident type 2 diabetes in the Etude Epidémiologique auprès des femmes de la Mutuelle Générale de l’Education Nationale–European Prospective Investigation into Cancer and Nutrition cohort.” Am J Clin Nutr. 2013, Jan 30; doi: 10.3945/ ajcn.112.050997 ajcn.050997. (abstract/article)

[32] Suez J et al. “Artificial sweeteners induce glucose intolerance by altering the gut microbiota.” Nature. 2014 Oct 9;514(7521). PMID: 25231862. (abstract / article)

[33] Kuk JL, Brown RE. “Aspartame intake is associated with greater glucose intolerance in individuals with obesity.” Appl Physiol Nutr Metab. 2016 Jul;41(7):795-8. doi: 10.1139/apnm-2015-0675. Epub 2016 May 24. (abstract)

[34] Palmnäs MSA, Cowan TE, Bomhof MR, Su J, Reimer RA, Vogel HJ, et al. (2014) Low-Dose Aspartame Consumption Differentially Affects Gut Microbiota-Host Metabolic Interactions in the Diet-Induced Obese Rat. PLoS ONE 9(10): e109841. (article)

[35] Halldorsson TI, Strøm M, Petersen SB, Olsen SF. “Intake of artificially sweetened soft drinks and risk of preterm delivery: a prospective cohort study in 59,334 Danish pregnant women.” Am J Clin Nutr. 2010 Sep;92(3):626-33. PMID: 20592133. (abstract / article)

[36] Meghan B. Azad, PhD; Atul K. Sharma, MSc, MD; Russell J. de Souza, RD, ScD; et al. “Association Between Artificially Sweetened Beverage Consumption During Pregnancy and Infant Body Mass Index.” JAMA Pediatr. 2016;170(7):662-670. (abstract)

[37] Mueller NT, Jacobs DR Jr, MacLehose RF, Demerath EW, Kelly SP, Dreyfus JG, Pereira MA. “Consumption of caffeinated and artificially sweetened soft drinks is associated with risk of early menarche.” Am J Clin Nutr. 2015 Sep;102(3):648-54. doi: 10.3945/ajcn.114.100958. Epub 2015 Jul 15. (abstract)

[38] Ashok I, Poornima PS, Wankhar D, Ravindran R, Sheeladevi R. “Oxidative stress evoked damages on rat sperm and attenuated antioxidant status on consumption of aspartame.” Int J Impot Res. 2017 Apr 27. doi: 10.1038/ijir.2017.17. (abstract / article)

[39] Finamor I, Pérez S, Bressan CA, Brenner CE, Rius-Pérez S, Brittes PC, Cheiran G, Rocha MI, da Veiga M, Sastre J, Pavanato MA., “Chronic aspartame intake causes changes in the trans-sulphuration pathway, glutathione depletion and liver damage in mice.” Redox Biol. 2017 Apr;11:701-707. doi: 10.1016/j.redox.2017.01.019. Epub 2017 Feb 1. (abstract/article)

[40] Lebda MA, Tohamy HG, El-Sayed YS. “Long-term soft drink and aspartame intake induces hepatic damage via dysregulation of adipocytokines and alteration of the lipid profile and antioxidant status.” Nutr Res. 2017 Apr 19. pii: S0271-5317(17)30096-9. doi: 10.1016/j.nutres.2017.04.002. [Epub ahead of print] (abstract)

[41] Sharma A, Amarnath S, Thulasimani M, Ramaswamy S. “Artificial sweeteners as a sugar substitute: Are they really safe?” Indian J Pharmacol 2016;48:237-40 (article)